A detailed characterization of the adult mouse model of glycogen storage disease Ia

被引:14
作者
Salganik, Susan V. [1 ,2 ]
Weinstein, David A. [3 ]
Shupe, Thomas D. [1 ,2 ]
Salganik, Max [4 ]
Pintilie, Dana G. [1 ,2 ]
Petersen, Bryon E. [1 ,2 ]
机构
[1] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
[2] Univ Florida, Coll Med, Program Stem Cell Biol & Regenerat Med, Gainesville, FL 32610 USA
[3] Univ Florida, Coll Med, Dept Pediat, Div Pediat Endocrinol, Gainesville, FL 32610 USA
[4] Univ Florida, Coll Med, Powell Gene Therapy Ctr, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA
关键词
Glucose-6-phosphatase; GSD1a mouse model; glycogen storage disease; hypoglycemia; metabolic disorder; MEDIATED GENE-THERAPY; MURINE GLUCOSE-6-PHOSPHATASE; 1A; HYPOGLYCEMIA; MUTATIONS; ADENOMAS; TYPE-1A; CANINE; LIVER; MICE;
D O I
10.1038/labinvest.2009.64
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Glycogen storage disease type Ia (GSDIa) is caused by a genetic defect in the hepatic enzyme glucose-6-phosphatase (G6Pase-alpha), which manifests as life-threatening hypoglycemia with related metabolic complications. A G6Pase-alpha knockout (KO) mouse model was generated to study potential therapies for correcting this disorder. Since then, gene therapy studies have produced promising results, showing long-term improvement in liver histology and glycogen metabolism. Under existing protocols, however, untreated KO pups seldom survived weaning. Here, we present a thorough characterization of the G6Pase-alpha KO mouse, as well as the husbandry protocol for rearing this strain to adulthood. These mice were raised with only palliative care, and characterized from birth through 6 months of age. Once KO mice have survived the very frail weaning period, their size, agility, serum lipids and glycemic control improve dramatically, reaching levels approaching their wild-type littermates. In addition, our data reveal that adult mice lacking G6Pase-alpha are able to mate and produce viable offspring. However, liver histology and glycogen accumulation do not improve with age. Overall, the reliable production of mature KO mice could provide a critical tool for advancing the GSDIa field, as the availability of a robust enzyme-deficient adult offers a new spectrum of treatment avenues that would not be tolerated by the frail pups. Most importantly, our detailed characterization of the adult KO mouse provides a crucial baseline for accurately gauging the efficacy of experimental therapies in this important model. Laboratory Investigation (2009) 89, 1032-1042; doi:10.1038/labinvest.2009.64; published online 6 July 2009
引用
收藏
页码:1032 / 1042
页数:11
相关论文
共 50 条
  • [41] Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
    Derks, Terry G. J.
    Rodriguez-Buritica, David F.
    Ahmad, Ayesha
    de Boer, Foekje
    Couce, Maria L.
    Gruenert, Sarah C.
    Labrune, Philippe
    Lopez Maldonado, Nerea
    Fischinger Moura de Souza, Carolina
    Riba-Wolman, Rebecca
    Rossi, Alessandro
    Saavedra, Heather
    Gupta, Rupal Naik
    Valayannopoulos, Vassili
    Mitchell, John
    NUTRIENTS, 2021, 13 (11)
  • [42] The signaling pathways implicated in impairment of hepatic autophagy in glycogen storage disease type Ia
    Gautam, Sudeep
    Zhang, Lisa
    Arnaoutova, Irina
    Lee, Cheol
    Mansfield, Brian C.
    Chou, Janice Y.
    HUMAN MOLECULAR GENETICS, 2020, 29 (05) : 834 - 844
  • [43] Molecular diagnosis of glycogen storage disease type IX using a glycogen storage disease gene panel
    Kim, Tae Hyeong
    Kim, Kwang Yeon
    Kim, Man Jin
    Seong, Moon-Woo
    Park, Sung Sup
    Moon, Jin Soo
    Ko, Jae Sung
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2020, 63 (06)
  • [44] Clinical features of gout in adult patients with type Ia glycogen storage disease: a single-centre retrospective study and a review of literature
    Xu, Na
    Han, Xinxin
    Zhang, Yun
    Huang, Xiaoming
    Zhu, Weiguo
    Shen, Min
    Zhang, Wen
    Jialin, Chen
    Wei, Min
    Qiu, Zhengqing
    Zeng, Xuejun
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [45] Clinical features of gout in adult patients with type Ia glycogen storage disease: a single-centre retrospective study and a review of literature
    Na Xu
    Xinxin Han
    Yun Zhang
    Xiaoming Huang
    Weiguo Zhu
    Min Shen
    Wen Zhang
    Chen Jialin
    Min Wei
    Zhengqing Qiu
    Xuejun Zeng
    Arthritis Research & Therapy, 24
  • [46] Dietary dilemmas in the management of glycogen storage disease type I
    Bhattacharya, Kaustuv
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 (03) : 621 - 629
  • [47] Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a
    Janice Yang Chou
    Adriana Zingone
    Chi-Jiunn Pan
    European Journal of Pediatrics, 2002, 161 (1) : S56 - S61
  • [48] Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk
    Hironori Nagasaka
    Ken-ichi Hirano
    Akira Ohtake
    Takashi Miida
    Tomozumi Takatani
    Kei Murayama
    Tohru Yorifuji
    Kunihiko Kobayashi
    Masaki Kanazawa
    Atsushi Ogawa
    Masaki Takayanagi
    European Journal of Pediatrics, 2007, 166 : 1009 - 1016
  • [49] Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk
    Nagasaka, Hironori
    Hirano, Ken-ichi
    Ohtake, Akira
    Miida, Takashi
    Takatani, Tomozumi
    Murayama, Kei
    Yorifuji, Tohru
    Kobayashi, Kunihiko
    Kanazawa, Masaki
    Ogawa, Atsushi
    Takayanagi, Masaki
    EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (10) : 1009 - 1016
  • [50] Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a
    Chou, JY
    Zingone, A
    Pan, CJ
    EUROPEAN JOURNAL OF PEDIATRICS, 2002, 161 (Suppl 1) : S56 - S61